Advertisement

Index by author

May 01, 2012; Volume 81,Issue 5

A

  1. Abramkin, Sergey A.

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  2. Acher, F.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  3. Ameling, S.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

B

  1. Bareford, M. Danielle

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

  2. Barrie, Elizabeth S.

    1. mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604

  3. Battaglia, G.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  4. Berger, Walter

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  5. Bertrand, H. O.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  6. Bien, S.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  7. Bonner, Lisa A.

    1. Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339

  8. Borland, Gillian

    1. Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976

  9. Brown, Alastair J. H.

    1. Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
      Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
      Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388

  10. Bruno, V.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  11. Bytzek, Anna K.

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

C

  1. Chemel, Benjamin R.

    1. Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339

  2. Chen, Xing-Juan

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

  3. Cruickshanks, Nichola

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

  4. Curini, M.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

D

  1. de Jong, Steven

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  2. Dent, Paul

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

  3. Dever, Daniel P.

    1. The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
      Daniel P. Dever and Lisa A. Opanashuk
      Molecular Pharmacology May 2012, 81 (5) 669-678; DOI: https://doi.org/10.1124/mol.111.077305

  4. de Vries, Elisabeth G. E.

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  5. Dhankher, Persis

    1. A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026

  6. Di Marco, R.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  7. Du, Xiao-Na

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

  8. Dunlop, Julia

    1. Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976

F

  1. Fazio, F.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  2. Fisher, Paul B.

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

  3. Fujimoto, Katsumi

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

G

  1. Galanski, Markus

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  2. Gao, Shan

    1. Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976

  3. Gill, JasKiran K.

    1. A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026

  4. Gojo, Johannes

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  5. Goudet, C.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  6. Grant, Steven

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

H

  1. Hamamura, Kengo

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  2. Hamed, Hossein A.

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

  3. Hammer, E.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  4. Hanada, Yuichi

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  5. Hartinger, Christian G.

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  6. Heffeter, Petra

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  7. Herzog, S.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  8. Holliday, Nicholas D.

    1. Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
      Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
      Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388

  9. Hougardy, Brigitte M. T.

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  10. Huang, Dong-Yang

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

  11. Hussner, J.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

I

  1. Inoue, Miki

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

J

  1. Jakupec, Michael A.

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  2. Jia, Zhan-Feng

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

  3. Jungwirth, Ute

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

K

  1. Kakimoto, Keisuke

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  2. Keppler, Bernhard K.

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  3. Körner, Wilfried

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

  4. Koyanagi, Satoru

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  5. Kroemer, H. K.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  6. Kusunose, Naoki

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

L

  1. Lionetto, L.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  2. Liu, Bo-Yi

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

M

  1. Matsunaga, Naoya

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  2. Meersma, Gert J.

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  3. Millar, Neil S.

    1. A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026

  4. Molinaro, G.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

N

  1. Ngomba, R. T.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  2. Nichols, David E.

    1. Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339

  3. Nicoletti, F.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  4. Niessen, J.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  5. Notartomaso, S.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

O

  1. Ohdo, Shigehiro

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  2. Opanashuk, Lisa A.

    1. The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
      Daniel P. Dever and Lisa A. Opanashuk
      Molecular Pharmacology May 2012, 81 (5) 669-678; DOI: https://doi.org/10.1124/mol.111.077305

P

  1. Pin, J. P.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  2. Poklepovic, Andrew

    1. Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

R

  1. Ritter, C. A.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  2. Rosati, O.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

S

  1. Sadee, Wolfgang

    1. mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604

  2. Sanford, Jonathan C.

    1. mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604

  3. Sato, Fuyuki

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

  4. Scarselli, P.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  5. Schaap, Bessel

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  6. Schroeder, H. W. S.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  7. Schwebe, M.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

  8. Sheppard, Tom D.

    1. A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026

  9. Sher, Emanuele

    1. A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026

  10. Simmaco, M.

    1. Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

  11. Smith, Ryan M.

    1. mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604

  12. Steil, L.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

T

  1. Tan, Shinta

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  2. Toi, Ayumi

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

V

  1. van der Zee, Ate G. J.

    1. Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539

  2. Völker, U.

    1. Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

W

  1. Watson, Sarah-Jane

    1. Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
      Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
      Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388

  2. Watts, Val J.

    1. Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339

  3. Wiejak, Jolanta

    1. Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976

  4. Windberger, Ursula

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

X

  1. Xanthos, Dimitris N.

    1. Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

Y

  1. Yarwood, Stephen J.

    1. Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976

  2. Yoshiyama, Yuji

    1. Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

Z

  1. Zhang, Guo-Hong

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

  2. Zhang, Hai-Lin

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

  3. Zhang, Xuan

    1. Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
Back to top

In this issue